Close
  Indian J Med Microbiol
 

Table 1: Tissue microarray data with cohorts from (a) estrogen receptor(+) invasive ductal carcinoma, (b) estrogen receptor(+) invasive lobular carcinoma, (c) estrogen receptor(−) invasive ductal carcinoma, and (d) human epidermal growth factor 2(+) invasive ductal carcinoma. Spot number refers to the location on the TMA. The two numbers reported in the cell count column refer to the number of cells in the high-signal and low - signal populations, respectively, where the data were partitioned based on biomarker signal intensities (see Figure 3a for more details). (c) Spots 91 and 89 in ER(−) IDC are anomalous in that the ER staining was observed in the normal epithelium and not in the cancer cells. These spots were erroneously assigned the category of ER(−) IDC by the automated image processing algorithms. These errors could be avoided by having pathologists manually determine regions of interests. TMA: Tissue microarray, ER: Estrogen receptor IDC: Invasive ductal carcinoma

Table 1: Tissue microarray data with cohorts from (a) estrogen receptor(+) invasive ductal carcinoma, (b) estrogen receptor(+) invasive lobular carcinoma, (c) estrogen receptor(−) invasive ductal carcinoma, and (d) human epidermal growth factor 2(+) invasive ductal carcinoma. Spot number refers to the location on the TMA. The two numbers reported in the cell count column refer to the number of cells in the high-signal and low - signal populations, respectively, where the data were partitioned based on biomarker signal intensities (see Figure 3a for more details). (c) Spots 91 and 89 in ER(−) IDC are anomalous in that the ER staining was observed in the normal epithelium and not in the cancer cells. These spots were erroneously assigned the category of ER(−) IDC by the automated image processing algorithms. These errors could be avoided by having pathologists manually determine regions of interests. TMA: Tissue microarray, ER: Estrogen receptor IDC: Invasive ductal carcinoma